Targeted Treatment Focus Specializes in interventional psychiatry with FDA-cleared treatments like Deep TMS and Spravato, indicating opportunities to cross-sell complementary neuromodulation and pharmacotherapy services to clinics and hospitals expanding treatment-resistant depression programs.

Mid-Size Growth Current revenue range ($1M-$10M) and headcount (11-50) suggest a scalable, lean operation open to partnerships, managed services, or white-label solutions that complement smaller to mid-market healthcare providers seeking cost-effective expansion.

Urban Accessibility Downtown Columbus location signals potential for partnerships with local primary care networks, employers, and HR programs seeking convenient, on-site or easily referable mental health services for employee well-being initiatives.

Digital Footprint Reliance on GoDaddy for tech stack indicates potential for upgraded digital marketing, patient acquisition channels, and technology integrations (telehealth portals, CRM) to scale patient reach and streamline referrals.

Competitive Positioning Operate in a niche with peers of varying scale; opportunities exist to differentiate through outcomes data, payer partnerships, and expanded offerings (kombining TMS, Spravato, and interventional psychiatry) to win referral business from larger providers.